Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100137

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100137

MEA Whole Exome Sequencing Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Middle East & Africa whole exome sequencing (WES) market is projected to register a substantial CAGR of 8.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.

Market Segmentation:

Whole Exome Sequencing (WES) Market, By Component (Second generation sequencing and Third-Generation sequencing), Product and Service (systems, kits and services), Application (Drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others ), End User (pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others), Distribution Channel (direct trade, retail sales and others), Industry Trends and Forecast to 2029.

Middle East & Africa whole exome sequencing (WES) market is categorized into four notable segment which is Component, Product and Service, Application, End User and Distribution Channel.

On the basis of component, the global whole exome sequencing (WES) market is segmented into second generation sequencing and third-generation sequencing.

On the basis of Product and Service, the global whole exome sequencing (WES) market is segmented into systems, kits and services.

On the basis of Application, the global whole exome sequencing (WES) market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.

On the basis of End user, the global whole exome sequencing (WES) market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others.

On the basis of Distribution Channel, the global whole exome sequencing (WES) market is segmented into direct trade, retail sales and others.

Some of the major factors contributing to the growth of the Middle East & Africa whole exome sequencing (WES) market are:

Increase in the adoption of whole exome sequencing (WES)

Growing usage of targeted sequencing methods

Market Players:

The key market players for Middle East & Africa whole exome sequencing (WES) market are listed below:

GeneDx, LLC

Psomagen

Integrated DNA Technologies, Inc., among others.

TABLE OF CONTENTS

1 INTRODUCTION 33

  • 1.1 OBJECTIVES OF THE STUDY 33
  • 1.2 MARKET DEFINITION 33
  • 1.3 OVERVIEW OF MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET 33
  • 1.4 CURRENCY AND PRICING 35
  • 1.5 LIMITATIONS 35
  • 1.6 MARKETS COVERED 36

2 MARKET SEGMENTATION 39

  • 2.1 MARKETS COVERED 39
  • 2.2 GEOGRAPHICAL SCOPE 40
  • 2.3 YEARS CONSIDERED FOR THE STUDY 41
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 42
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45
  • 2.6 MULTIVARIATE MODELLING 46
  • 2.7 MARKET APPLICATION COVERAGE GRID 47
  • 2.8 PRODUCT TYPE LIFELINE CURVE 48
  • 2.9 DBMR MARKET POSITION GRID 49
  • 2.10 VENDOR SHARE ANALYSIS 51
  • 2.11 SECONDARY SOURCES 52
  • 2.12 ASSUMPTIONS 52

3 EXECUTIVE SUMMARY 53

4 PREMIUM INSIGHT 57

  • 4.1 PORTER'S FIVE FORCES 58
  • 4.2 PESTEL ANALYSIS 59
  • 4.3 INDUSTRIAL INSIGHTS: 60
  • 4.4 CONCLUSION 61

5 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: REGULATIONS 62

6 MARKET OVERVIEW 64

  • 6.1 DRIVERS 66
    • 6.1.1 GROWING USAGE OF TARGETED SEQUENCING METHODS 66
    • 6.1.2 INCREASE IN THE ADOPTION OF NEXT GENERATION SEQUENCING 66
    • 6.1.3 INCREASING DIAGNOSTICS APPLICATIONS OF WHOLE EXOME SEQUENCING 66
    • 6.1.4 INCREASE TREND TOWARD PERSONALIZED MEDICATION 67

  • 6.2 RESTRAINTS 68
    • 6.2.1 LESS COMPREHENSIVE COVERAGE OF EXONS 68
    • 6.2.2 CYBER SECURITY CONCERNS IN GENOMICS 68
  • 6.3 OPPORTUNITIES 69
    • 6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 69
    • 6.3.2 INCREASING PRODUCT LAUNCHES IN RECENT YEARS 69
  • 6.4 CHALLENGES 70
    • 6.4.1 LACK OF SKILLED PROFESSIONALS 70
    • 6.4.2 ETHICAL AND LEGAL ISSUES RELATED TO WHOLE EXOME SEQUENCING 70

7 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT 71

  • 7.1 OVERVIEW 72
  • 7.2 SECOND-GENERATION SEQUENCING 75
    • 7.2.1 SEQUENCING BY SYNTHESIS (SBS) 76
    • 7.2.2 SEQUENCING BY HYBRIDIZATION (SBH) AND SEQUENCING BY LIGATION (SBL) 76
  • 7.3 THIRD-GENERATION SEQUENCING 77

8 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE 78

  • 8.1 OVERVIEW 79
  • 8.2 SYSTEMS 82
    • 8.2.1 HISEQ SERIES 83
      • 8.2.1.1 HISEQ 2500 83
      • 8.2.1.2 HISEQ 1500 83
    • 8.2.2 MISEQ SERIES 83
    • 8.2.3 ION TORRENT PLATFORMS 84
      • 8.2.3.1 ION PROTON 84
      • 8.2.3.2 ION PGM 84
    • 8.2.4 OTHERS 84
  • 8.3 KITS 84
    • 8.3.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS 85
    • 8.3.2 LIBRARY PREPARATION KITS 85
    • 8.3.3 TARGET ENRICHMENT KITS 86
    • 8.3.4 OTHERS 86
  • 8.4 SERVICES 86
    • 8.4.1 SEQUENCING SERVICES 87
    • 8.4.2 DATA ANALYSIS (BIOINFORMATICS) SERVICES 87
    • 8.4.3 OTHERS 87

9 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION 88

  • 9.1 OVERVIEW 89
  • 9.2 DRUG DISCOVERY AND DEVELOPMENT 92
  • 9.3 AGRICULTURE & ANIMAL RESEARCH 93
  • 9.4 DIAGNOSTICS 93
  • 9.5 PERSONALIZED MEDICINE 94
  • 9.6 OTHERS 95

10 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY END USER 96

  • 10.1 OVERVIEW 97
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 100
  • 10.3 ACADEMIC & RESEARCH INSTITUTES 101
  • 10.4 HOSPITALS AND CLINICS 101
  • 10.5 CLINICAL LABORATORIES 102
  • 10.6 OTHERS 103

11 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL 104

  • 11.1 OVERVIEW 105
  • 11.2 DIRECT TRADE 108
  • 11.3 RETAIL SALES 108
  • 11.4 OTHERS 110

12 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY REGION 111

  • 12.1 MIDDLE EAST AND AFRICA 112
    • 12.1.1 SOUTH AFRICA 120
    • 12.1.2 SAUDI ARABIA 124
    • 12.1.3 U.A.E 128
    • 12.1.4 ISRAEL 131
    • 12.1.5 EGYPT 134
    • 12.1.6 REST OF MIDDLE EAST AND AFRICA 137

13 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: COMPANY LANDSCAPE 138

  • 13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 138

14 COMPANY PROFILE 139

  • 14.1 PERKINELMER GENOMICS (A SUBSIDIARY OF PERKINELMER INC.) 139
    • 14.1.1 COMPANY SNAPSHOT 139
    • 14.1.2 REVENUE ANALYSIS 139
    • 14.1.3 COM PANY SHARE ANALYSIS 140
    • 14.1.4 PRODUCT PORTFOLIO 140
    • 14.1.5 RECENT DEVELOPMENTS 140
  • 14.2 MERCK KGAA 142
    • 14.2.1 COMPANY SNAPSHOT 142
    • 14.2.2 REVENUE ANALYSIS 142
    • 14.2.3 COM PANY SHARE ANALYSIS 143
    • 14.2.4 PRODUCT PORTFOLIO 143
    • 14.2.5 RECENT DEVELOPMENTS 143
  • 14.3 EXODX (A PART OF BIO-TECHNE) 144
    • 14.3.1 COMPANY SNAPSHOT 144
    • 14.3.2 REVENUE ANALYSIS 144
    • 14.3.3 COM PANY SHARE ANALYSIS 145
    • 14.3.4 PRODUCT PORTFOLIO 145
    • 14.3.5 RECENT DEVELOPMENTS 145
  • 14.4 THERMO FISHER SCIENTIFIC INC. 146
    • 14.4.1 COMPANY SNAPSHOT 146
    • 14.4.2 REVENUE ANALYSIS 146
    • 14.4.3 COM PANY SHARE ANALYSIS 147
    • 14.4.4 PRODUCT PORTFOLIO 147
    • 14.4.5 RECENT DEVELOPMENTS 147
  • 14.5 FOUNDATION MEDICINE, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 148
    • 14.5.1 COMPANY SNAPSHOT 148
    • 14.5.2 REVENUE ANALYSIS 148
    • 14.5.3 COM PANY SHARE ANALYSIS 149
    • 14.5.4 PRODUCT PORTFOLIO 149
    • 14.5.5 RECENT DEVELOPMENTS 149
  • 14.6 AZENTA US, INC. 151
    • 14.6.1 COMPANY SNAPSHOT 151
    • 14.6.2 PRODUCT PORTFOLIO 151
    • 14.6.3 RECENT DEVELOPMENTS 151
  • 14.7 BECKMAN COULTER, INC 153
    • 14.7.1 COMPANY SNAPSHOT 153
    • 14.7.2 REVENUE ANALYSIS 153
    • 14.7.3 PRODUCT PORTFOLIO 154
    • 14.7.4 RECENT DEVELOPMENTS 154
  • 14.8 BIONEER CORPORATION 155
    • 14.8.1 COMPANY SNAPSHOT 155
    • 14.8.2 REVENUE ANALYSIS 155
    • 14.8.3 PRODUCT PORTFOLIO 156
    • 14.8.4 RECENT DEVELOPMENTS 156
  • 14.9 CD GENOMICS 157
    • 14.9.1 COMPANY SNAPSHOT 157
    • 14.9.2 PRODUCT PORTFOLIO 157
    • 14.9.3 RECENT DEVELOPMENTS 157
  • 14.10 CEGAT GMBH 158
    • 14.10.1 COMPANY SNAPSHOT 158
    • 14.10.2 PRODUCT PORTFOLIO 158
    • 14.10.3 RECENT DEVELOPMENTS 158
  • 14.11 EUROFINS SCIENTIFIC 159
    • 14.11.1 COMPANY SNAPSHOT 159
    • 14.11.2 REVENUE ANALYSIS 159
    • 14.11.3 PRODUCT PORTFOLIO 160
    • 14.11.4 RECENT DEVELOPMENTS 160
  • 14.12 GENEDX, LLC 161
    • 14.12.1 COMPANY SNAPSHOT 161
    • 14.12.2 PRODUCT PORTFOLIO 161
    • 14.12.3 RECENT DEVELOPMENTS 161
  • 14.13 GENEFIRST LIMITED. 163
    • 14.13.1 COMPANY SNAPSHOT 163
    • 14.13.2 PRODUCT PORTFOLIO 163
    • 14.13.3 RECENT DEVELOPMENTS 163
  • 14.14 ILLUMINA, INC 165
    • 14.14.1 COMPANY SNAPSHOT 165
    • 14.14.2 REVENUE ANALYSIS 165
    • 14.14.3 PRODUCT PORTFOLIO 166
    • 14.14.4 RECENT DEVELOPMENTS 166
  • 14.15 INTEGRATED DNA TECHNOLOGIES, INC. 168
    • 14.15.1 COMPANY SNAPSHOT 168
    • 14.15.2 PRODUCT PORTFOLIO 168
    • 14.15.3 RECENT DEVELOPMENTS 168
  • 14.16 MERIDIAN BIOSCIENCE, INC. 170
    • 14.16.1 COMPANY SNAPSHOT 170
    • 14.16.2 REVENUE ANALYSIS 170
    • 14.16.3 PRODUCT PORTFOLIO 171
    • 14.16.4 RECENT DEVELOPMENTS 171
  • 14.17 PSOMAGEN 172
    • 14.17.1 COMPANY SNAPSHOT 172
    • 14.17.2 REVENUE ANALYSIS 172
    • 14.17.3 PRODUCT PORTFOLIO 172
    • 14.17.4 RECENT DEVELOPMENTS 173
  • 14.18 QIAGEN 174
    • 14.18.1 COMPANY SNAPSHOT 174
    • 14.18.2 REVENUE ANALYSIS 174
    • 14.18.3 PRODUCT PORTFOLIO 175
    • 14.18.4 RECENT DEVELOPMENTS 175
  • 14.19 SOPHIA GENETICS 176
    • 14.19.1 COMPANY SNAPSHOT 176
    • 14.19.2 REVENUE ANALYSIS 176
    • 14.19.3 PRODUCT PORTFOLIO 177
    • 14.19.4 RECENT DEVELOPMENTS 177
  • 14.20 TWIST BIOSCIENCE 178
    • 14.20.1 COMPANY SNAPSHOT 178
    • 14.20.2 REVENUE ANALYSIS 178
    • 14.20.3 PRODUCT PORTFOLIO 179
    • 14.20.4 RECENT DEVELOPMENTS 179

15 QUESTIONNAIRE 181

16 RELATED REPORTS 184

LIST OF TABLES

  • TABLE 1 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 58
  • TABLE 2 MIDDLE EAST & AFRICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 59
  • TABLE 3 MIDDLE EAST & AFRICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 60
  • TABLE 4 MIDDLE EAST & AFRICA THIRD-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 61
  • TABLE 5 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 65
  • TABLE 6 MIDDLE EAST & AFRICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 66
  • TABLE 7 MIDDLE EAST & AFRICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 66
  • TABLE 8 MIDDLE EAST & AFRICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 67
  • TABLE 9 MIDDLE EAST & AFRICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 68
  • TABLE 10 MIDDLE EAST & AFRICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 69
  • TABLE 11 MIDDLE EAST & AFRICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 69
  • TABLE 12 MIDDLE EAST & AFRICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 70
  • TABLE 13 MIDDLE EAST & AFRICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 71
  • TABLE 14 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 75
  • TABLE 15 MIDDLE EAST & AFRICA DRUG DISCOVERY AND DEVELOPMENT IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 76
  • TABLE 16 MIDDLE EAST & AFRICA AGRICULTURE & ANIMAL RESEARCH IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 77
  • TABLE 17 MIDDLE EAST & AFRICA DIAGNOSTICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 78
  • TABLE 18 MIDDLE EAST & AFRICA PERSONALIZED MEDICINE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 79
  • TABLE 19 MIDDLE EAST & AFRICA OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 79
  • TABLE 20 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 83
  • TABLE 21 MIDDLE EAST & AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 84
  • TABLE 22 MIDDLE EAST & AFRICA ACADEMIC & RESEARCH INSTITUTES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 85
  • TABLE 23 MIDDLE EAST & AFRICA HOSPITALS AND CLINICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 86
  • TABLE 24 MIDDLE EAST & AFRICA CLINICAL LABORATORIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 87
  • TABLE 25 MIDDLE EAST & AFRICA OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 87
  • TABLE 26 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 91
  • TABLE 27 MIDDLE EAST & AFRICA DIRECT TRADE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 92
  • TABLE 28 MIDDLE EAST & AFRICA RETAIL SALES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 93
  • TABLE 29 MIDDLE EAST & AFRICA OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION) 94
  • TABLE 30 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 100
  • TABLE 31 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 100
  • TABLE 32 MIDDLE EAST AND AFRICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 100
  • TABLE 33 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 100
  • TABLE 34 MIDDLE EAST AND AFRICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 101
  • TABLE 35 MIDDLE EAST AND AFRICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 101
  • TABLE 36 MIDDLE EAST AND AFRICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 101
  • TABLE 37 MIDDLE EAST AND AFRICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 101
  • TABLE 38 MIDDLE EAST AND AFRICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 102
  • TABLE 39 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 102
  • TABLE 40 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 102
  • TABLE 41 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 103
  • TABLE 42 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 104
  • TABLE 43 SOUTH AFRICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 104
  • TABLE 44 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 104
  • TABLE 45 SOUTH AFRICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 105
  • TABLE 46 SOUTH AFRICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 105
  • TABLE 47 SOUTH AFRICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 105
  • TABLE 48 SOUTH AFRICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 105
  • TABLE 49 SOUTH AFRICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 106
  • TABLE 50 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 106
  • TABLE 51 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 106
  • TABLE 52 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 107
  • TABLE 53 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 108
  • TABLE 54 SAUDI ARABIA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 108
  • TABLE 55 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 108
  • TABLE 56 SAUDI ARABIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 109
  • TABLE 57 SAUDI ARABIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 109
  • TABLE 58 SAUDI ARABIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 109
  • TABLE 59 SAUDI ARABIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 109
  • TABLE 60 SAUDI ARABIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 110
  • TABLE 61 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 110
  • TABLE 62 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 110
  • TABLE 63 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 111
  • TABLE 64 U.A.E WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 112
  • TABLE 65 U.A.E SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 112
  • TABLE 66 U.A.E WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 112
  • TABLE 67 U.A.E SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 112
  • TABLE 68 U.A.E HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 113
  • TABLE 69 U.A.E ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 113
  • TABLE 70 U.A.E KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 113
  • TABLE 71 U.A.E SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 113
  • TABLE 72 U.A.E WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 114
  • TABLE 73 U.A.E WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 114
  • TABLE 74 U.A.E WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 114
  • TABLE 75 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 115
  • TABLE 76 ISRAEL SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 115
  • TABLE 77 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 115
  • TABLE 78 ISRAEL SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 115
  • TABLE 79 ISRAEL HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 116
  • TABLE 80 ISRAEL ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 116
  • TABLE 81 ISRAEL KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 116
  • TABLE 82 ISRAEL SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 116
  • TABLE 83 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 117
  • TABLE 84 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 117
  • TABLE 85 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 117
  • TABLE 86 EGYPT WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 118
  • TABLE 87 EGYPT SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 118
  • TABLE 88 EGYPT WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 118
  • TABLE 89 EGYPT SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 118
  • TABLE 90 EGYPT HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 91 EGYPT ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 92 EGYPT KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 93 EGYPT SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION) 119
  • TABLE 94 EGYPT WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 120
  • TABLE 95 EGYPT WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION) 120
  • TABLE 96 EGYPT WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 120
  • TABLE 97 REST OF MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION) 121

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 22
  • FIGURE 2 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: DATA TRIANGULATION 25
  • FIGURE 3 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: DROC ANALYSIS 26
  • FIGURE 4 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 27
  • FIGURE 5 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: COMPANY RESEARCH ANALYSIS 27
  • FIGURE 6 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: INTERVIEW DEMOGRAPHICS 28
  • FIGURE 7 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: MARKET APPLICATION COVERAGE GRID 30
  • FIGURE 8 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: DBMR MARKET POSITION GRID 32
  • FIGURE 9 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: VENDOR SHARE ANALYSIS 34
  • FIGURE 10 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION 38
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 39
  • FIGURE 12 INCREASE IN USE OF WES TECHNOLOGY FOR NEW SCIENTIFIC APPLICATIONS AND INCREASING THE PREFERENCE OF WES OVER WHOLE-GENOME SEQUENCING IS ITS LOW-COST SEQUENCING CAPABILITY IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 40
  • FIGURE 13 THE INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING (WES) MARKET IN 2022 & 2029 40
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET 48
  • FIGURE 15 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2021 55
  • FIGURE 16 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022-2029 (USD MILLION) 56
  • FIGURE 17 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, CAGR (2022-2029) 56
  • FIGURE 18 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, LIFELINE CURVE 57
  • FIGURE 19 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2021 62
  • FIGURE 20 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2022-2029 (USD MILLION) 63
  • FIGURE 21 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, CAGR (2022-2029) 63
  • FIGURE 22 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE 64
  • FIGURE 23 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2021 72
  • FIGURE 24 LOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 73
  • FIGURE 25 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, CAGR (2022-2029) 73
  • FIGURE 26 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE 74
  • FIGURE 27 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2021 80
  • FIGURE 28 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY END USER, 2022-2029 (USD MILLION) 81
  • FIGURE 29 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY END USER, CAGR (2022-2029) 81
  • FIGURE 30 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY END USER, LIFELINE CURVE 82
  • FIGURE 31 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2021 88
  • FIGURE 32 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 89
  • FIGURE 33 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 89
  • FIGURE 34 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 90
  • FIGURE 35 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021) 96
  • FIGURE 36 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021) 97
  • FIGURE 37 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029) 97
  • FIGURE 38 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029) 98
  • FIGURE 39 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029) 98
  • FIGURE 40 MIDDLE EAST & AFRICA WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%) 121
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!